Tag Archives: Medivation

August, 2016

  • 22 August

    Pfizer to Acquire Medivation for $14 Billion

    NEW YORK & SAN FRANCISCO–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) and Medivation, Inc. (NASDAQ:MDVN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total …

May, 2016

  • 2 May

    Medivation Rejects Sanofi’s Takeover Bid

    SAN FRANCISCO, CA  — (Marketwired) — 04/29/16 — Medivation, Inc. (NASDAQ: MDVN) today announced that its Board of Directors, after consultation with its financial and legal advisors, unanimously determined that the unsolicited proposal from Sanofi to acquire Medivation for $52.50 per share in cash substantially undervalues Medivation and is not …

April, 2016

  • 29 April

    Sanofi Offers $9.3 Billion to Buy Cancer Drugmaker Medivation

    Paris, April 28, 2016 – Sanofi today announced that it has sent a letter to Medivation, Inc., in which it makes a non-binding proposal to acquire Medivation for $52.50 per share. This would represent an all-cash transaction valued at approximately $9.3 billion.[1] Combining Sanofi and Medivation represents a compelling strategic …